Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation

A comparison of rate control and rhythm control in patients with atrial fibrillation

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405 · see citing works

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.009 · Cited by 1,157 · see citing works

Amiodarone versus sotalol for atrial fibrillation

Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041705 · Cited by 749 · see citing works

Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation

Stambler, B. S., Wood, M. A., Ellenbogen, K. A., Perry, K. T., Wakefield, L. K., & VanderLugt, J. T. (1996) · Circulation · doi:10.1161/01.cir.94.7.1613 · Cited by 485 · see citing works

Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study

Singh, S., Zoble, R. G., Yellen, L., Brodsky, M. A., Feld, G. K., Berk, M., & Billing, C. B. (2000) · Circulation · doi:10.1161/01.cir.102.19.2385 · Cited by 433 · see citing works

Facilitating Transthoracic Cardioversion of Atrial Fibrillation with Ibutilide Pretreatment

Oral, H., Souza, J. J., Michaud, G. F., Knight, B. P., Goyal, R., Strickberger, S. A., & Morady, F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402401 · Cited by 354 · see citing works

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

SUTTORP, M. J., Kingma, J. H., JESSURUN, E. R., Lie‐A‐Huen, L., van Hemel, N. M., & Lie, K. I. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90326-k · Cited by 282 · see citing works

Conversion Efficacy and Safety of Intravenous Ibutilide Compared With Intravenous Procainamide in Patients With Atrial Flutter or Fibrillation 11This study was sponsored by Pharmacia & Upjohn, Kalamazoo, Michigan.22See Appendix Afor a complete list of investigators and study sites.

Volgman, A. S., Carberry, P. A., Stambler, B., Lewis, W. R., Dunn, G. H., Perry, K. T., VanderLugt, J. T., & Kowey, P. R. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00078-3 · Cited by 242 · see citing works

Intravenous Dofetilide, a Class III Antiarrhythmic Agent, for the Termination of Sustained Atrial Fibrillation or Flutter

Falk, R. H., Pollak, A., Singh, S. N., & Friedrich, T. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00506-2 · Cited by 215 · see citing works

Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations

Carlsson, L. M. S., Abrahamsson, C., Andersson, B., Duker, G., & Schiller-Linhardt, G. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2186 · Cited by 213 · see citing works

Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation

Vos, M. A., Golitsyn, S. R., Stangl, K., Ruda, M. Y., Van Wijk, L., Harry, J. D., Perry, K. T., Touboul, P., Steinbeck, G., & Wellens, H. J. J. (1998) · Heart · doi:10.1136/hrt.79.6.568 · Cited by 200 · see citing works

Efficacy and Safety of Ibutilide Fumarate for the Conversion of Atrial Arrhythmias After Cardiac Surgery

VanderLugt, J. T., Mattioni, T. A., Denker, S. T., Torchiana, D. F., AHERN, T. S., Wakefield, L. K., Perry, K. T., & Kowey, P. R. (1999) · Circulation · doi:10.1161/01.cir.100.4.369 · Cited by 191 · see citing works

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)

Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm315 · Cited by 185 · see citing works

A comparison of rate control and rhythm control in patients with atrial fibrillation

The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00084-9 · Cited by 169 · see citing works

Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion

Fenster, P. E., Comess, K. A., Marsh, R., Katzenberg, C., & Hager, W. D. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90692-0 · Cited by 157 · see citing works

Antiarrhythmic Actions of Intravenous Ibutilide Compared With Procainamide During Human Atrial Flutter and Fibrillation: Electrophysiological Determinants of Enhanced Conversion Efficacy

Stambler, B. S., Wood, M. A., & Ellenbogen, K. A. (1997) · Circulation · doi:10.1161/01.cir.96.12.4298 · Cited by 156 · see citing works

Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation

Khan, I. A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01116-5 · Cited by 144 · see citing works

Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/Flutter

Kowey, P. R., VanderLugt, J. T., & Luderer, J. R. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00566-8 · Cited by 133 · see citing works

Efficacy, Safety, and Determinants of Conversion of Atrial Fibrillation and Flutter With Oral Amiodarone

Tieleman, R. G., Gosselink, A. T. M., Crijns, H. J. G. M., Gelder, I. C. V., van den Berg, M. P., de Kam, P. J., van Gilst, W. H., & Lie, K. I. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00675-3 · Cited by 121 · see citing works

Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: Results of a comparative study and a 2-year follow-up

Zehender, M., Hohnloser, S. H., Müller, B. W., Meinertz, T., & Just, H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90294-w · Cited by 115 · see citing works

Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset

Reisinger, J. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.04.030 · Cited by 103 · see citing works

Comparative Assessment of Ibutilide, D-Sotalol, Clofilium, E-4031, and UK-68, 798 in a Rabbit Model of Proarrhythmia

Buchanan, L. V., Kabell, G., Brunden, M. N., & Gibson, J. K. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199310000-00006 · Cited by 97 · see citing works

Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation

Khan, I. A., Mehta, N. J., & Gowda, R. M. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00477-1 · Cited by 94 · see citing works

Torsade de pointes: the clinical considerations

Gowda, R. M., Khan, I. A., Wilbur, S. L., Vasavada, B. C., & Sacchi, T. J. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.04.055 · Cited by 93 · see citing works

Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study

Kochiadakis, G. E., Igoumenidis, N. E., Parthenakis, F., CHLOUVERAKIS, G. I., & Vardas, P. E. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00678-0 · Cited by 87 · see citing works

Female preponderance in ibutilide-induced torsade de pointes

Gowda, R. M., Khan, I. A., Punukollu, G., Vasavada, B. C., Sacchi, T. J., & Wilbur, S. L. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.04.034 · Cited by 87 · see citing works

Acute pharmacologic conversion of atrial fibrillation and flutter: The role of flecainide, propafenone, and verapamil

Kingma, J. H., & SUTTORP, M. J. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91079-j · Cited by 87 · see citing works

Electrophysiological effects of ibutilide in patients with accessory pathways

Glatter, K. A., Dorostkar, P. C., Yang, Y., Lee, R. J., Van Hare, G. F., Keung, E., Modin, G., & Scheinman, M. M. (2001) · Circulation · doi:10.1161/hc4101.097538 · Cited by 86 · see citing works

Electrophysiology and Pharmacology of Ibutilide

Naccarelli, G. V., Lee, K. S., Gibson, J. K., & VanderLugt, J. T. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00560-7 · Cited by 85 · see citing works

Classification and mechanism of initiation in patients with congenital long QT syndrome

NODA, T., SHIMIZU, W., SATOMI, K., SUYAMA, K., KURITA, T., AIHARA, N., & KAMAKURA, S. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.08.020 · Cited by 83 · see citing works

Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation

Khan, I. A. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00467-9 · Cited by 73 · see citing works

Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation

Abi‐Mansour, P., Carberry, P. A., McCowan, R. J., Henthorn, R. W., Dunn, G. H., & Perry, K. T. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70010-9 · Cited by 71 · see citing works

Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter

Kafkas, N. V., Patsilinakos, S. P., Mertzanos, G. A., Papageorgiou, K. I., Chaveles, J. I., Dagadaki, O. K., & Kelesidis, K. M. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.07.017 · Cited by 70 · see citing works

Chemical Cardioversion of Atrial Fibrillation or Flutter With Ibutilide in Patients Receiving Amiodarone Therapy

Glatter, K., Yang, Y., Chatterjee, K., Modin, G. W., Cheng, J., Kayser, S., & Scheinman, M. M. (2001) · Circulation · doi:10.1161/01.cir.103.2.253 · Cited by 69 · see citing works

Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial

Galperín, J., Elizari, M. V., Chiale, P. A., Molina, R. T., Ledesma, R., Scapín, A. O., & Blanco, M. V. (2001) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840100600403 · Cited by 68 · see citing works

Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing

Stambler, B. S., Wood, M. A., & Ellenbogen, K. A. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00010-0 · Cited by 59 · see citing works

Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability

Guo, G. B.-F., Ellenbogen, K. A., Wood, M. A., & Stambler, B. S. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00607-9 · Cited by 53 · see citing works

The Safety and Efficacy of Ibutilide in Children and in Patients with Congenital Heart Disease

Hoyer, A. W., & Balaji, S. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00799.x · Cited by 52 · see citing works

Electropharmacologic Effects of Class I and Class III Antiarrhythmia Drugs on Typical Atrial Flutter

Tai, C. T., Chen, S., Feng, A.-N., Yu, W., Chen, Y., & Chang, M.-S. (1998) · Circulation · doi:10.1161/01.cir.97.19.1935 · Cited by 49 · see citing works

Acute Hemodynamic Effects of Intravenous Ibutilide in Patients With or Without Reduced Left Ventricular Function

Stambler, B. S., Beckman, K. J., Kadish, A. H., Camm, A. J., Ellenbogen, K. A., Perry, K., & VanderLugt, J. T. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00395-0 · Cited by 46 · see citing works

Ibutilide versus amiodarone in atrial fibrillation: A double-blinded, randomized study

Bernard, E. O., Schmid, E. R., Schmidlin, D., Scharf, C., CANDINAS, R., & Germann, R. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000053555.78624.0f · Cited by 45 · see citing works

Effect of High Doses of Magnesium on Converting Ibutilide to a Safe and More Effective Agent

Patsilinakos, S. P., Christou, A. H., Kafkas, N. V., Nikolaou, N. I., Antonatos, D. G., Katsanos, S., SPANODIMOS, S. G., & Babalis, D. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.04.020 · Cited by 45 · see citing works

Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation

Simpson, C. S., Yee, R. K., Lee, J. K., Braney, M., Klein, G. J., Krahn, A. D., & Skanes, A. C. (2001) · American Heart Journal · doi:10.1067/mhj.2001.116767 · Cited by 43 · see citing works

Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents

Hongo, R. H., Themistoclakis, S., Raviele, A., Bonso, A., Rossillo, A., Glatter, K. A., Yang, Y., & Scheinman, M. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.051 · Cited by 42 · see citing works

Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter

Chiladakis, J. A., Kalogeropoulos, A. P., Πατσούρας, Ν., & Manolis, A. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.056 · Cited by 39 · see citing works

Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: neither strategy improves outcomes compared to rate control alone (the PIPAF study).

Soucier, R. J., Silverman, D. I., Abordo, M. G., Jaagosild, P., Abiose, A. K., Madhusoodanan, K. P., Therrien, M. L., Lippman, N., Dalamagas, H. C., & Berns, E. (2003) · PubMed · Cited by 31 · see citing works

Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter

Steinwender, C., Hönig, S., Kypta, A., Kammler, J., Schmitt, B. A., Leisch, F., & Hofmann, R. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.12.012 · Cited by 19 · see citing works

Electrophysiological Response of the Right Atrium to Ibutilide During Typical Atrial Flutter

Cheng, J., Glatter, K. A., Yang, Y., Zhang, S., Lee, R. J., & Scheinman, M. M. (2002) · Circulation · doi:10.1161/01.cir.0000025635.38200.75 · Cited by 17 · see citing works

Pharmacologic Reversion of Persistent Atrial Fibrillation with Amiodarone Predicts Long-Term Sinus Rhythm Maintenance

Galperín, J., Elizari, M. V., Chiale, P. A., Molina, R. T., Ledesma, R., Scapín, A. O., Blanco, M. V., Bonato, R., Lago, M., & Grupo de Estudio de Fibrilación Auricular Con Amiodarona (GEFACA) Investigators (2003) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840300800302 · Cited by 17 · see citing works

Acute Conversion of Persistent Atrial Fibrillation During Dofetilide Initiation

Cotiga, D., Arshad, A., Aziz, E. F., Joshi, S. A., Koneru, J. N., & Steinberg, J. S. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00902.x · Cited by 16 · see citing works

Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter

Zaqqa, M., Afshar, H., Rasekh, A., Khoshnevis, R., Vaughn, W. K., & Massumi, A. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00619-0 · Cited by 14 · see citing works

Use of Ibutilide for Cardioversion of Recent-Onset Atrial Fibrillation and Flutter in Elderly

Gowda, R. M., Khan, I. A., Punukollu, G., Mendoza, C., Wilbur, S. L., Vasavada, B. C., & Sacchi, T. J. (2004) · American Journal of Therapeutics · doi:10.1097/00045391-200403000-00003 · Cited by 13 · see citing works

Intravenous antiarrhythmic agents

Pintér, A., & Dorian, P. (2001) · Current Opinion in Cardiology · doi:10.1097/00001573-200101000-00003 · Cited by 13 · see citing works

Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation

KHAN, I. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00334-8 · Cited by 13 · see citing works

Is pretreatment with ibutilide useful for atrial fibrillation cardioversion when combined with biphasic shock?

Mazzocca, G., CORBUCCI, G., Venturini, E., & Becuzzi, L. (2006) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000203851.75020.bd · Cited by 12 · see citing works

Classification and mechanism of torsade de pointes initiation in patients with congenital long QT syndrome

Noda, T., Shimizu, W., & Satomi, K. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.03.034 · Cited by 11 · see citing works

Amiodarone Versus Sotalol for Atrial Fibrillation

Waldo, A. L. (2006) · Yearbook of Cardiology · doi:10.1016/s0145-4145(07)70269-1 · Cited by 10 · see citing works

Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter

Chiladakis, J. A., Kalogeropoulos, A. P., Πατσούρας, Ν., & Manolis, A. S. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.10.065 · Cited by 6 · see citing works

Ibutilide for cardioversion of atrial flutter: efficacy of a single dose in recent-onset arrhythmias.

Andò, G., Rosa, S. D., Rizzo, F., Carerj, S., Bramanti, O., Giannetto, M., & Arrigo, F. (2004) · PubMed · Cited by 5 · see citing works

Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents

Hongo, R. H., Themistoclakis, S., & Raviele, A. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.10.064 · Cited by 5 · see citing works

Cost Analysis of Transthoracic Cardioversion of Atrial Fibrillation With and Without Ibutilide Pretreatment

Oral, H., Knight, B. P., Sticherling, C., Kim, M. H., Baker, R. L., Chough, S. P., Wasmer, K., Pelosi, F., Michaud, G. F., Fendrick, A. M., et al. (2000) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1054/jcpt.2000.16696 · Cited by 3 · see citing works

[Pharmacological cardioversion with intravenous propafenone in atrial fibrillation].

Rodrı́guez, E. V., Rodríguez, C. C., Estrada, S., Rojo, J. R., Morales, E. H., & Muñoz, A. U. (2000) · PubMed · Cited by 2 · see citing works

[Pharmacological cardioversion with intravenous propafenone in atrial fibrillation].

Velázquez Rodríguez, E., Rodríguez, C. C., Arias Estrada, S., et al. (2000) · PubMed · Cited by 1 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418 · see citing works

2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Gelder, I. C. V., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., Potter, T. J. R. D., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,338 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403 · see citing works

Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

Dan, G., Martínez‐Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaïta, F., Gelder, I. C. V., Görenek, B., Kaski, J. C., Kjeldsen, K. P., et al. (2018) · EP Europace · doi:10.1093/europace/eux373 · Cited by 234 · see citing works

Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

Merino, J. L., Tamargo, J. L., Blomström‐Lundqvist, C., Boriani, G., Crijns, H. J. G. M., Dobrev, D., Goette, A., Hohnloser, S. H., Naccarelli, G. V., Reiffel, J. A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf076 · Cited by 105 · see citing works

Management of Arrhythmias in Heart Failure

Masarone, D., Limongelli, G., Rubino, M., Valente, F., Vastarella, R., Ammendola, E., Gravino, R., Verrengia, M., Salerno, G., & Pacileo, G. (2017) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd4010003 · Cited by 85 · see citing works

Management of atrial fibrillation: two decades of progress — a scientific statement from the European Cardiac Arrhythmia Society

Lévy, S., Steinbeck, G., Santini, L., Näbauer, M., Penela, D., Kantharia, B. K., Saksena, S. V., & Cappato, R. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01195-z · Cited by 50 · see citing works

Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department

Vinson, D. R., Lugovskaya, N., Warton, E. M., Rome, A. M., Stevenson, M. D., Reed, M., Nagam, M. R., & Ballard, D. W. (2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.07.481 · Cited by 33 · see citing works

Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

Kraft, M., Büscher, A., Wiedmann, F., L’hoste, Y., Haefeli, W. E., Frey, N., Katus, H. A., & Schmidt, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.638445 · Cited by 31 · see citing works

Contemporary analysis of incidence of post-operative atrial fibrillation, its predictors, and association with clinical outcomes in lung transplantation

Raghavan, D., Gao, A., Ahn, C. W., Torres, F., Mohanka, M. R., Bollineni, S., Peltz, M., Wait, M. A., Ring, S., & Kaza, V. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.09.032 · Cited by 29 · see citing works

Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study

Lévy, S., Hartikainen, J. E. K., Ritz, B. R., Juhlin, T., Carbajosa-Dalmau, J., & Domanovits, H. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07103-9 · Cited by 23 · see citing works

Safety and efficacy of pharmacological cardioversion of recent-onset atrial fibrillation: a single-center experience

Kriz, R., Freynhofer, M. K., Weiss, T. W., Egger, F., Gruber, S. C., Eisenburger, P., Wojta, J., Huber, K., & Koch, J. (2016) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2016.05.012 · Cited by 23 · see citing works

Pharmacotherapeutic strategies for atrial fibrillation in pregnancy

Georgiopoulos, G. A., Tsiachris, D., Kordalis, A., Kontogiannis, C., Spartalis, Μ., Pietri, P., Magkas, N., & Stefanadis, C. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1621290 · Cited by 22 · see citing works

Management of arrhythmias in pulmonary hypertension

Reddy, S. A., Nethercott, S. L., Khialani, B. V., Grace, A. A., & Martin, C. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-021-00988-y · Cited by 10 · see citing works

Management of atrial fibrillation in the Emergency Department: current approach and future expectations.

Russo, V., Navarin, S., Zampini, G., Magrini, L., Mann, C., Muiesan, M. L., Caterina, R. D., Yılmaz, M. B., Beton, O., Monzani, V., et al. (2013) · PubMed · Cited by 10 · see citing works

Atrial Fibrillation: Antiarrhythmic Therapy

Psotka, M. A., & Lee, B. K. (2014) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2014.07.004 · Cited by 9 · see citing works

Use of intravenous vernakalant for atrial fibrillation conversion in the regular ward under only bedside monitoring

Manolis, A. S., Bethanis, S., Metaxa, S., Polytarchou, K., Sakellaris, N., & Pyrros, I. (2018) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2018.02.003 · Cited by 8 · see citing works

Comparative Effectiveness of Direct Current Cardioversion in Patients With Atrial Fibrillation and Obesity With Body Mass Index ≥50 kg/m2

Lacoste, J. L., Avalon, J. C., Ludhwani, D., Conte, J., Perkowski, G., Patel, B., Courser, A., & Balla, S. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.06.121 · Cited by 7 · see citing works

Pharmacological cardioversion of atrial fibrillation: practical considerations

Wybraniec, M. T., Kampka, Z., & Mizia­‐Stec, K. (2023) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16547 · Cited by 6 · see citing works

Safety and Efficacy of Ibutilide for Acute Pharmacological Cardioversion of Rheumatic Atrial Fibrillation

Shenthar, J., Banavalikar, B., Valappil, S. P., Deshpande, S. A., Nireshwalia, A., Padmanabhan, D., & Reddy, S. (2021) · Cardiology · doi:10.1159/000516590 · Cited by 6 · see citing works

Cardioversion of recent‐onset atrial fibrillation using intravenous antiarrhythmics: A European perspective

Lévy, S. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15264 · Cited by 6 · see citing works

Mechanisms of Chemical Atrial Defibrillation by Flecainide and Ibutilide

Yang, P., Belardinelli, L., & Clancy, C. E. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.08.009 · Cited by 4 · see citing works

Class III Antiarrhythmic Drugs

Tamargo, J. L., Caballero, R., & Delpón, E. (2020) · Springer eBooks · doi:10.1007/978-3-030-34893-9_3 · Cited by 4 · see citing works

Arrhythmias

Heijman, J., & Dobrev, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00082-7 · Cited by 3 · see citing works

ECG Diagnosis: Ibutilide-induced Torsade de Pointes

Le, D. D., Levis, J. T., Lugovskaya, N., & Vinson, D. R. (2019) · The Permanente Journal · doi:10.7812/tpp/18-187 · Cited by 2 · see citing works

Investigation of the antifibrillatory drug interactions between Amiodarone and Ibutilide in isolated, perfused Rabbit hearts

Almotrefi, A. A., Bukhari, I. A., & Al-Humayyd, M. S. (2015) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12141 · Cited by 2 · see citing works

Cardioversion in atrial fibrillation. Focus on recent-onset atrial fibrillation

Tampieri, A., Rusconi, A. M., & Lenzi, T. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0863-0 · Cited by 2 · see citing works

Ibutilide and novel indexes of ventricular repolarization in persistent atrial fibrillation patients

Korantzopoulos, P. G. (2013) · World Journal of Cardiology · doi:10.4330/wjc.v5.i7.242 · Cited by 2 · see citing works

Atrial fibrillation in pregnancy

Georgiopoulos, G. A., Margioula, E., O’Neill, L., & Chatzidou, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817728-0.00061-9 · Cited by 2 · see citing works

Family Practice is a Highly Complex Business

Bowman, M. A., & Neale, A. V. (2011) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2011.01.100261 · Cited by 2 · see citing works

Atrial Fibrillation: Rate Versus Rhythm Control

Vargas, C., Bhatnagar, M., Ahmed, H. S., Flynn, M. G., & Alexander, T. (2023) · HCA Healthcare Journal of Medicine · doi:10.36518/2689-0216.1564 · Cited by 1 · see citing works

Class III Antiarrhythmic Drugs

Delpón, E., Caballero, R., & Tamargo, J. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-74046-6_5 · Cited by 1 · see citing works

Clinical Efficacy and Safety of Ibutilide in Cardioversion of Atrial Fibrillation or Flutter in Indian Patients: A Multicenter Study

Dewan, B., Navale, S., Shinde, S., & Chaudhary, J. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24885 · Cited by 1 · see citing works

Efficacy of Ibutilide for Terminating Recent Onset Atrial Fibrillation- A Single Centre Study

Soumya, M., Khasim, S., Reddy, K. R., Arramraju, S. K., Mudgalkar, N., & Baviskar, A. (2021) · PERSPECTIVES IN MEDICAL RESEARCH · doi:10.47799/pimr.0902.16 · Cited by 1 · see citing works

Cardioversion of recent-onset atrial fibrillation and flutter in the emergency department

Beton, O., Yılmaz, M. B., Korkmaz, Ö., Berkan, Ö., & Tandoğan, İ. (2014) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/1305-0028.2247

Ibutilide for the Cardioversion of Paroxysmal Atrial Fibrillation during Radiofrequency Ablation of Supraventricular Tachycardias

Polymeropoulos, K., Vassilikos, V. P., Mantziari, L., Paraskevaidis, S., Karamitsos, T. D., Mochlas, S., Parcharidis, G. E., Louridas, G. E., & Stylıadis, I. (2011) · Cardiology Research and Practice · doi:10.4061/2011/270143

Anti-arrhythmic Agents

Al-Shura, A. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817580-4.00005-6

Conversion of Persistent Atrial Fibrillation After Radiofrequency Ablation by Ibutilide.

Kojodjojo, P. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.500

Comparing efficacy of ibutilide and amiodarone for cardioversion in atrial fibrillation after coronary artery bypass grafting- A prospective and randomized study

Godara, M., Goyal, P. K., Goyal, S. K., & Carpenter, D. (2021) · Indian Journal of Clinical Anaesthesia · doi:10.18231/j.ijca.2021.035

Atrial Fibrillation

Harrison, E. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-26415-3_5

Aleteo auricular: caso clínico

Santos, E. J. B., Rivas, R. J. M., & Corte, A. M. Y. (2024) · Anatomía Digital · doi:10.33262/anatomiadigital.v7i1.2898

ACE Question

(2017) · ASA Monitor · doi:10.1097/01.asm.0001075576.89203.81

Observation on effectiveness and safety of ibutilide in pharmacological cardioversion of atrial fibrillation or atrial flutter to normal sinus rhythm

Li, L. (2013) · Journal of clinical and experimental medicine

Ibutilide: what's clinically proven, what's being investigated?

Britto, N., & Das, M. K. (2026) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2026.02.013 · Cited by 1 · see citing works

Acute management of atrial fibrillation and atrial flutter in the critical care unit: shouLd it be ibutilide?

Varriale, P., & Sedighi, A. (2000) · Clinical Cardiology · doi:10.1002/clc.4960230408 · Cited by 24 · see citing works

Ibutilide: Efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice

Eversole, A., Hancock, W., Johns, T., Lopez, L. M., & Conti, C. R. (2001) · Clinical Cardiology · doi:10.1002/clc.4960240709 · Cited by 19 · see citing works

The convert research of ibutilide injection for cardioversion of atrial fibrillation and atrial flutter to sinus rhythm

Wan, Z. (2006) · Tianjin Yike Daxue xuebao